How did Bio-Techne's revenue and expenses trend in Q2 2025?

Bio-Techne's revenue and expenses trends in Q2 2025 are not available.

1. Revenue Trends: The specific revenue figures for Q2 2025 are not provided. However, it is known that Bio-Techne reported a 6% organic revenue increase and robust performance in protein sciences in Q3 2025, which suggests that the company's revenue trend was positive, albeit specific Q2 2025 figures are not available.

2. Expense Trends: There are no available data on Bio-Techne's expenses for Q2 2025. However, the company's financial statements for Q3 2025 are detailed in press releases and reports, which include information on net earnings, adjustments for reconciling net earnings to cash provided by operating activities, depreciation, and amortization. The lack of Q2 2025 data prevents a comprehensive analysis of expense trends during that quarter.

The absence of Q2 2025 revenue and expense data leaves gaps in analyzing Bio-Techne's financial performance during that period. However, the available data for Q3 2025 indicates a positive revenue trend with strong performance in key segments, which could be indicative of the company's continued growth and operational efficiency.